Compounds > bufalin

bufalin and Pancreatic Neoplasms

bufalin has been researched along with Pancreatic Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Abd El-Aty, AM; Ashrafizadeh, M; Cheng, Y; Fan, Y; Fang, S; Gong, P; Hacimuftuoglu, A; Hu, M; Li, W; Linnebacher, M; Shi, D; Yuan, J; Zhang, J; Zhang, W; Zhang, X	1
Guo, H; Li, J; Li, M; Liu, Q; Sun, L; Wang, A; Wang, X; Yu, X	1
Li, Y; Meng, Z; Ning, Z; Wang, H; Zhu, X	1
Chen, L; Fu, HY; Liu, X; Shou, QY; Wang, JC; Xiao, XY; Yan, JF	1

Other Studies

4 other study(ies) available for bufalin and Pancreatic Neoplasms

Article	Year
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2023, Volume: 71 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cell Membrane; Drug Resistance, Multiple; Mice; Pancreatic Neoplasms	2023
Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bufanolides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Pancreatic Neoplasms; Signal Transduction	2014
Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Molecular medicine reports, 2016, Volume: 14, Issue:3 Topics: Animals; Bufanolides; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hedgehog Proteins; Humans; Mice; Neoplastic Stem Cells; Pancreatic Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays	2016
Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of ethnopharmacology, 2016, Dec-04, Volume: 193 Topics: Animals; Antineoplastic Agents; Bufanolides; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases; Male; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; S Phase Cell Cycle Checkpoints; Signal Transduction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays	2016